Archive · 8 Dec 2025
Corona Remedies IPO Sees Moderate Start
Corona Remedies, a medicine company, started selling shares to the public on December 8, 2025.
This is called an IPO, and it's worth ₹655.37 crore.
The price for each share is between ₹1,008 and ₹1,062.
In the grey market, shares are trading higher, but this is not official.
The IPO is only for selling existing shares, not for raising new money.
Regular investors can buy a minimum of 14 shares.
The subscription is open until December 10, and the company is expected to start trading on the stock market on December 15.
The IPO has seen moderate interest, with retail investors showing more enthusiasm than institutional investors.
The company is valued at nearly ₹6,500 crore.
Corona Remedies IPO opens for subscription on December 8, 2025, with a ₹655.37 crore Offer for Sale.
Price band set between ₹1,008-1,062 per share, with a grey market premium around ₹290.
IPO is structured entirely as an Offer for Sale, with no fresh capital raised for the company.
Retail investors can apply for a minimum of 14 shares, with higher minimums for HNIs and employees.
Subscription window closes on December 10, with expected listing on December 15.
- Who
- Corona Remedies, a pharmaceutical company
- What
- Initial Public Offering (IPO) opening for subscription
- When
- December 8-10 (subscription), expected listing on December 15
- Where
- India
- Why
- To allow existing shareholders to sell their shares (Offer for Sale)
- IPO Type
- Offer for Sale
- Issue Size
- ₹655.37 crore
- Price Band
- ₹1,008-1,062 per share
- Grey Market Premium
- ₹290 (unofficial)
- Retail Lot Size
- 14 shares (minimum)
- Subscription Window
- December 8-10
- Expected Listing Date
- December 15
- Book Running Lead Manager
- JM Financial, IIFL Capital Services, Kotak Mahindra Capital Company
- Registrar
- Bigshare Services Pvt. Ltd.
- Company Valuation
- ₹6,500 crore
- Anchor Investors
- SBI Mutual Fund, ICICI Prudential Mutual Fund, HDFC Mutual Fund, Kotak Mutual Fund, Axis Mutual Fund, DSP Mutual Fund, Invesco Mutual Fund, SBI Life Insurance Company
- Shares Allotted to Anchors
- 18.36 lakh shares at ₹1,062 per share
- Retail Subscription
- 0.56 times
- Non-Institutional Subscription
- 0.41 times
- Employee Quota Subscription
- 0.85 times
- QIB Subscription
- 0 times (as of December 8, 2025)
Sources
Corona Remedies IPO opens today: From GMP, price band to issue size, 5 ‘must-know’ details
Corona Remedies IPO Day 1: Check GMP, subscription status, key dates, review and other details - should you subscribe?
LIVE: Aequs IPO allotment today- GMP slips from last week’s highs, below 30%
Corona Remedies IPO Day 1 LIVE: Issue opens today. GMP, subscription status, review, other key things. Apply or not?
Corona Remedies IPO opens today: Should you subscribe to this issue?
LIVE: Corona Remedies IPO opens – Check Day 1 subscription of Rs 655 crore issue, price band and key details
Corona Remedies IPO off to a moderate start with 37% subscription
Prodocs Solutions IPO day 1: GMP, subscription status, price band, other details of BSE SME IPO
Corona Remedies public issue opens today at ₹1,008-1,062 price band
